The tumor volume of Tf-L-APVN treated mice was 4.6-fold, 3-fold, 3.6-fold and 2.4-fold smaller compared to tumor volume of mice treated with control, free PTX, free VOR, and cocktail PTX/VOR, respectively. This evidence concerns the gene TF and neoplasm.